3M Forecast, price target & analysts
3M Target price 2025 - Analyst rating & recommendation
3M Classifications & Recommendation:
3M Price Target
| Target Price | $153.47 |
| Price | $141.12 |
| Potential | 8.75% |
| Number of Estimates | 15 |
| 15 Analysts have issued a price target 3M 2026 . The average 3M target price is $153.47. This is 8.75% higher than the current stock price. The highest price target is $184.00 30.39% , the lowest is $100.00 29.14% . | |
| A rating was issued by 20 analysts: 11 Analysts recommend 3M to buy, 6 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the 3M stock has an average upside potential 2026 of 8.75% . Most analysts recommend the 3M stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
14 Analysts have issued a sales forecast 3M 2025 . The average 3M sales estimate is $23.9b . This is 2.60% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $24.4b 0.51% , the lowest is $23.3b 5.09% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $24.6b | 0.14% |
|---|---|---|
| 2025 | $23.9b | 2.85% |
| 2026 | $24.6b | 2.83% |
| 2027 | $25.3b | 3.02% |
| 2028 | $26.1b | 3.13% |
| 2029 | $27.4b | 5.00% |
13 Analysts have issued an 3M EBITDA forecast 2025. The average 3M EBITDA estimate is $6.7b . This is 8.85% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.9b 12.66% , the lowest is $6.4b 3.81% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $6.2b | 12.32% |
|---|---|---|
| 2025 | $6.7b | 8.66% |
| 2026 | $7.1b | 5.90% |
| 2027 | $7.5b | 5.86% |
| 2028 | $6.7b | 10.26% |
EBITDA Margin
| 2024 | 25.05% | 12.48% |
|---|---|---|
| 2025 | 28.01% | 11.84% |
| 2026 | 28.85% | 3.00% |
| 2027 | 29.64% | 2.74% |
| 2028 | 25.79% | 12.99% |
6 3M Analysts have issued a net profit forecast 2025. The average 3M net profit estimate is $4.2b . This is 1.23% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.3b 0.96% , the lowest is $4.2b 2.15% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $4.1b | 159.78% |
|---|---|---|
| 2025 | $4.2b | 3.61% |
| 2026 | $4.6b | 8.43% |
| 2027 | $5.1b | 11.01% |
Net Margin
| 2024 | 16.53% | 159.86% |
|---|---|---|
| 2025 | 17.63% | 6.63% |
| 2026 | 18.59% | 5.45% |
| 2027 | 20.04% | 7.80% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
6 Analysts have issued a 3M forecast for earnings per share. The average 3M EPS is $7.82 . This is 1.26% lower than earnings per share in the financial year 2024. The highest EPS forecast is $8.00 1.01% , the lowest is $7.75 2.15% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $7.55 | 159.78% |
|---|---|---|
| 2025 | $7.82 | 3.58% |
| 2026 | $8.48 | 8.44% |
| 2027 | $9.42 | 11.08% |
P/E ratio
| Current | 17.83 | 333.38% |
|---|---|---|
| 2025 | 18.04 | 1.18% |
| 2026 | 16.64 | 7.76% |
| 2027 | 14.99 | 9.92% |
Based on analysts' sales estimates for 2025, the 3M stock is valued at an EV/Sales of 3.48 and an P/S ratio of 3.18 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 3.39 | 70.35% |
|---|---|---|
| 2025 | 3.48 | 2.61% |
| 2026 | 3.38 | 2.75% |
| 2027 | 3.28 | 2.94% |
| 2028 | 3.18 | 3.03% |
| 2029 | 3.03 | 4.76% |
P/S ratio
| Current | 3.10 | 88.19% |
|---|---|---|
| 2025 | 3.18 | 2.67% |
| 2026 | 3.09 | 2.75% |
| 2027 | 3.00 | 2.94% |
| 2028 | 2.91 | 3.03% |
| 2029 | 2.77 | 4.77% |
Current 3M Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Underperform
➜
Underperform
|
Unchanged | Apr 23 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 23 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Apr 14 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 10 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 08 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Mar 06 2025 |
| RBC Capital |
Underperform
➜
Underperform
|
Unchanged | Feb 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
RBC Capital:
Underperform
➜
Underperform
|
Apr 23 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 23 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Apr 14 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 10 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 08 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Mar 06 2025 |
|
Unchanged
RBC Capital:
Underperform
➜
Underperform
|
Feb 27 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
